Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Gross Margin Over TimeContracting
Percentile Rank14
3Y CAGR-4.2%
5Y CAGR+1.3%
Year-over-Year Change
Gross profit as a percentage of revenue
3Y CAGR
-4.2%/yr
vs -2.2%/yr prior
5Y CAGR
+1.3%/yr
Recent deceleration
Acceleration
-2.0pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 56.56% | -10.8% |
| 2024 | 63.38% | -7.2% |
| 2023 | 68.33% | +6.2% |
| 2022 | 64.33% | +14.6% |
| 2021 | 56.12% | +6.1% |
| 2020 | 52.91% | -29.4% |
| 2019 | 74.92% | +6.5% |
| 2018 | 70.37% | -7.3% |
| 2017 | 75.87% | -1.2% |
| 2016 | 76.76% | - |